Check Out What Whales Are Doing With MRNA
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bearish stance on Moderna (NASDAQ:MRNA), with 80% of the spotted trades being bearish. The whales have been targeting a price range from $90.0 to $135.0 for Moderna over the last 3 months. HSBC has downgraded its action to Reduce with a price target of $97, while UBS upgraded its action to Buy with a price target of $191. Morgan Stanley has maintained their Equal-Weight rating on Moderna, with a price target of $128.
July 19, 2023 | 6:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A whale investor has taken a bearish stance on Moderna, with 80% of the spotted trades being bearish. HSBC has downgraded its action to Reduce with a price target of $97, while UBS upgraded its action to Buy with a price target of $191. Morgan Stanley has maintained their Equal-Weight rating on Moderna, with a price target of $128.
The bearish stance taken by a whale investor, along with the downgrade by HSBC, could potentially lead to a decrease in Moderna's stock price. However, the upgrades by UBS and Morgan Stanley might mitigate this impact to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100